Inventor · disambiguated record
Wolfgang Zauner
Also filed as: ZAUNER WOLFGANG
11 granted patents·14 pending applications·77 citations·filing 1995–2023
90Inventor score
Top patents by PatentIndex Score
25 records- 0189US7771728B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2006·Granted Aug 10, 2010·10 cites·13 claims
- 0287US7658928B2Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptideINTERCELL AG·Filed 2007·Granted Feb 9, 2010·6 cites·6 claims
- 0386US8323660B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2010·Granted Dec 4, 2012·7 cites·6 claims
- 0481US8715688B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2012·Granted May 6, 2014·3 cites·16 claims
- 0575US11065273B2Treatment and prevention of alzheimer's disease (AD)AFFIRIS AG·Filed 2015·Granted Jul 20, 2021·1 cites·15 claims
- 0675US7378234B2Method for isolating hepatitis C virus peptidesINTERCELL AG·Filed 2003·Granted May 27, 2008·11 cites·31 claims
- 0775US2024148782A1Treatment and prevention of alzheimer's disease (ad)ADVANTAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0874US7968297B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2002·Granted Jun 28, 2011·7 cites·16 claims
- 0971US11857568B2Treatment and prevention of Alzheimer's disease (AD)ADVANTAGE THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·19 claims
- 1070US8361476B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2001·Granted Jan 29, 2013·4 cites·5 claims
- 1170US5965404AMethod for introducing nucleic acids into higher eukaryotic cellsBOEHRINGER INGELHEIM INT·Filed 1995·Granted Oct 12, 1999·27 cites·49 claims
- 1267US8900564B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesFritz Jörg·Filed 2008·Granted Dec 2, 2014·1 cites·15 claims
- 1357US2009155294A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1456US2009130135A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1553US2013216583A1Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2013·Application pending·0 cites
- 1653US2015093432A1CompositionAFFIRIS AG·Filed 2013·Application pending·0 cites
- 1753US2007031446A1Hcv vaccinesINTERCELL AG·Filed 2004·Application pending·0 cites
- 1851US2009081246A1Method for isolating hepatitis c virus peptidesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1951US2016008443A1METHOD FOR TREATING A beta-AMYLOIDOSISAFFIRIS AG·Filed 2015·Application pending·0 cites
- 2051US2004170642A1Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereofFiled 2001·Application pending·0 cites
- 2150US2003095979A1Pharmaceutical preparations comprising modified peptidesCISTEM BIOTECHNOLOGIES GMBH·Filed 2002·Application pending·0 cites
- 2245US2011300170A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2011·Application pending·0 cites
- 2343US2009186047A1HCV VaccinationsINTERCELL AG·Filed 2006·Application pending·0 cites
- 2443US2005221381A1Method for isolating ligandsKLADE CHRISTOF·Filed 2003·Application pending·0 cites
- 2542US2008145383A1Method for Solubilizing Peptide MixturesINTERCELL AG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolfgang Zauner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →